Interpace Pharma Solutions business is focused on personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual.
Products being developed have the goals of transforming cancer patient management, increasing treatment efficacy, and reducing healthcare costs. Interpaces Pharma Solutions cutting-edge proprietary tests and state of the art reference lab provide genomic information where patients and their physicians need it most to diagnose, monitor and improve cancer treatment.
Our state of the art reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited. In addition we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey. Our extensive test menu is entirely focused on oncology and provides insights and clarity to inform and guide personalized cancer treatment through the use of our core labs in: Flow Cytometry, Molecular Diagnostics, Microarrays, Immunohistochemistry, Anatomical Pathology and Cytogenetics.
Candidates must be AP or AP/CP BE/BC with training and experience in surgical pathology and/or Molecular( NGS sign out experience preferrred) and/or Hematopathology. Candidates with subspecialty training and/or expertise in NGS, genomics or clinical trials, digital pathology will be given preference.
Summary of Functions:
Essential Duties and Responsibilities:
Review and annotate H&E slides for suitability for downstream testing methodologies.
Review, interpret and report diagnostic cases, including immunohistochemical (IHC), fluorescent in-situ hybridization (FISH), and molecular studies NGS (Illumina and IonTorrent platforms), Sanger sequencing, qPCR, fragment analysis - for hematological and solid tumors.
Provide direct consultations to clinical and biopharma/industry clients on medical significance of clinical laboratory data, using up-to-date scientific and medical knowledge.
Maintain up-to-date knowledge of established and evolving molecular diagnostic techniques and technologies, especially pertaining to: next-generation sequencing (NGS), molecular barcode-based assays, RNA-seq technologies, traditional (Sanger) sequencing and fragment analysis, qPCR, etc.
Assume an active role in development, optimization, and validation of new and existing assays in partnership with clients and internal laboratory, business development, and project management teams. Activities include, but are not limited to: sourcing reagents and specimens, drafting validation plans and reports, liaison building with vendors.
Follows and facilitates the implementation of all company policies and procedures outlined in Interpace Pharma Solutions active quality management program, and also all guidelines and regulations from governmental agencies such as CAP, FDA, CLIA, and NYSDOH.
Contribute as part of a cross-functional team to our clinical development strategy for various malignancies, which includes industry partnerships, conference presentations and exhibitions, field visits, and other related activities.
Support company mission and demonstrate company values as a strong team member and leader
Educational or Skill Requirements:
Required education: Medical doctor (MD/DO)
Board certification required: Anatomic Pathology or Anatomic Pathology/Clinical Pathology; and Molecular Genetic Pathology; and Hematopathology
Must have New Jersey / North Carolina State Medical License and New York accreditation.
Prefer minimum 2 years of experience signing out Molecular Diagnostic and Hematopathology cases; next-generation sequencing experience preferred.
Excellent professional communication skills, including verbal, written, and presentation.
Strong strategic, and proactive thinking skills; able to make and support decisions.
Strong scientific and analytical skills.
Interpace is an Equal Opportunity / Affirmative Action Employer